Actively Recruiting

Age: 30Years - 100Years
MALE
NCT03237026

Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients

Led by National Taiwan University Hospital · Updated on 2026-01-20

360

Participants Needed

1

Research Sites

720 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study aims to identify potential urine marker metabolites as predictive or prognostic markers for treatment outcomes in patients with prostate cancer.

CONDITIONS

Official Title

Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients

Who Can Participate

Age: 30Years - 100Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Histopathologically confirmed prostate adenocarcinoma
  • Age between 30 years and 100 years
  • Agree to undergo one of the following treatments: radical prostatectomy, definitive prostate radiotherapy, systemic chemotherapy, or androgen deprivation therapy
  • Understand and agree to comply with study procedures, including donating one 50 ml spot urine sample and allowing collection and analysis of clinical information
Not Eligible

You will not qualify if you...

  • Presence of other cancers not curatively treated or disease-free for 3 years or less; genitourinary cancers excluded regardless of disease-free duration
  • Severe organ function impairment affecting metabolism or proteomics, such as creatinine over 3.0, HbA1c over 9.0%, symptomatic heart failure, or other metabolic diseases
  • Significant infection or inflammation within 8 weeks before biopsy
  • Taking medications that substantially affect cell metabolism or proteomics as judged by investigators
  • Life expectancy less than 12 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Taiwan University

Taipei, Taiwan, 100

Actively Recruiting

Loading map...

Research Team

C

Chung-Hsin Chen, MD PhD

CONTACT

Y

Yeong-Shiau Pu, MD PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients | DecenTrialz